Strategic partnership will help improve health outcomes for patients with autoimmune disease

The American Autoimmune Related Diseases Association (AARDA) announced today a strategic alliance with iMD Health Global that will help evolve communications between physicians and patients to improve health outcomes, focused on autoimmune and related diseases, which is estimated to affect over 50 million Americans.

iMD Health offers innovative technology that facilitates meaningful dialogue between physicians and patients inside the examination room. iMD's award winning platform enables healthcare professionals to instantly access thousands of educational graphics, videos and resources at the point of care, across Canada and now expanding across the United States.

We believe the iMD platform will enhance how patients and physicians interact during a consult. With iMD, quick and easy access to a robust and visually appealing resource is now literally at the physician's fingertips. With a better understanding of their conditions, patients can make informed and responsible decisions about managing their health and the required steps to address their condition. We look forward to sharing our resources across North America, thereby providing physicians and patients greater access to the world class education by AARDA."

Virginia Ladd, Executive Director & President of AARDA in Eastpointe, MI

We are very excited about our new multi-year strategic partnership with AARDA. This partnership is a major step forward to improving patient education "At the Point of Care" related to autoimmune disease, from the highly recognized AARDA. As we expand our platform across the United States, this partnership with AARDA brings industry leading, respected information from the experts to affected individuals and their families."

Kevin Delano, President and CEO of iMD Health Global

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scaling organ‑chip technology for human‑relevant drug discovery